Financial statements Michel Laboratory Pawluczuk
Balance sheet data of MICHEL LABORATORY PAWLUCZUK
|
Year
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|
| Total assets | 8 631 129,81 | 8 380 662,10 | 7 925 000,69 | 8 639 300,51 |
| A. Fixed assets | 1 939 128,90 | 1 791 300,66 | 1 750 334,37 | 1 696 274,23 |
| B. Current assets | 6 692 000,91 | 6 589 361,44 | 6 174 666,32 | 6 943 026,28 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 8 631 129,81 | 8 380 662,10 | 7 925 000,69 | 8 639 300,51 |
| A. Equity | 4 585 413,99 | 4 168 510,05 | 3 251 577,42 | 3 375 904,36 |
| B. Liabilities and provisions for liabilities | 4 045 715,82 | 4 212 152,05 | 4 673 423,27 | 5 263 396,15 |
| I. Long-term liabilities | 1 291 910,00 | 2 205 384,48 | 2 128 009,40 | 2 403 638,64 |
| II. Short-term liabilities | 2 753 805,82 | 1 871 656,53 | 2 244 428,20 | 2 608 705,83 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.